[Prevention and treatment of febrile neutropenia].

@article{Montemurro1997PreventionAT,
  title={[Prevention and treatment of febrile neutropenia].},
  author={Filippo Montemurro and Margherita Gallicchio and Massimo Aglietta},
  journal={Tumori},
  year={1997},
  volume={83 2 Suppl},
  pages={S15-9}
}
Many chemotherapy regimens are associated with variable periods of myelosuppression. In cancer patients, neutropenia (less than 500 neutrophils/microL) is the most important risk factor for infections. The incidence and severity of infectious complications are related to depth and duration of neutropenia, with the highest risk if neutrophils are less than… CONTINUE READING